skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial
Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial

Passardi, A. ; Nanni, O. ; Tassinari, D. ; Turci, D. ; Cavanna, L. ; Fontana, A. ; Ruscelli, S. ; Mucciarini, C. ; Lorusso, V. ; Ragazzini, A. ; Frassineti, G.L. ; Amadori, D.

Annals of oncology, 2015-06, Vol.26 (6), p.1201-1207 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE

Mamounas, E.P. ; Untch, M. ; Mano, M.S. ; Huang, C.-S. ; Geyer Jr, C.E. ; von Minckwitz, G. ; Wolmark, N. ; Pivot, X. ; Kuemmel, S. ; DiGiovanna, M.P. ; Kaufman, B. ; Kunz, G. ; Conlin, A.K. ; Alcedo, J.C. ; Kuehn, T. ; Wapnir, I. ; Fontana, A. ; Hackmann, J. ; Polikoff, J. ; Saghatchian, M. ; Brufsky, A. ; Yang, Y. ; Zimovjanova, M. ; Boulet, T. ; Liu, H. ; Tesarowski, D. ; Lam, L.H. ; Song, C. ; Smitt, M. ; Loibl, S.

Annals of oncology, 2021-08, Vol.32 (8), p.1005-1014 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer

Vrdoljak, E. ; Marschner, N. ; Zielinski, C. ; Gligorov, J. ; Cortes, J. ; Puglisi, F. ; Aapro, M. ; Fallowfield, L. ; Fontana, A. ; Inbar, M. ; Kahan, Z. ; Welt, A. ; Lévy, C. ; Brain, E. ; Pivot, X. ; Putzu, C. ; González Martín, A. ; de Ducla, S. ; Easton, V. ; von Minckwitz, G.

Annals of oncology, 2016-11, Vol.27 (11), p.2046-2052 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Prognostic value of lymph node ratio in early breast cancer: a restrospective single institution analysis of clinical-pathological characteristics and outcomes
Prognostic value of lymph node ratio in early breast cancer: a restrospective single institution analysis of clinical-pathological characteristics and outcomes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic value of lymph node ratio in early breast cancer: a restrospective single institution analysis of clinical-pathological characteristics and outcomes

Diodati, L ; De Angelis, C ; Bertolini, I ; Montagnani, I ; Salvadori, B ; Ferrari, P ; Fontana, A

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi37-vi38 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
5
Expression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical response to CDK4/6 inhibitors in breast cancer
Expression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical response to CDK4/6 inhibitors in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Expression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical response to CDK4/6 inhibitors in breast cancer

Crucitta, S. ; Del Re, M. ; Fontana, A. ; Bertolini, I. ; Rofi, E. ; De Angelis, C. ; Diodati, L. ; Cavallero, D. ; Salvadori, B. ; Falcone, A. ; Morganti, R. ; Danesi, R.

Annals of oncology, 2018-10, Vol.29, p.viii46-viii46 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Effectiveness of trastuzumab emtansine (TDM1) in patients with HER2-positive advanced breast cancer (ABC) progressing after taxane plus pertuzumab plus trastuzumab
Effectiveness of trastuzumab emtansine (TDM1) in patients with HER2-positive advanced breast cancer (ABC) progressing after taxane plus pertuzumab plus trastuzumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effectiveness of trastuzumab emtansine (TDM1) in patients with HER2-positive advanced breast cancer (ABC) progressing after taxane plus pertuzumab plus trastuzumab

Conte, B. ; Fabi, A. ; Poggio, F. ; Blondeaux, E. ; Dellepiane, C. ; D'Alonzo, A. ; Staiano, A. ; Buono, G. ; Arpino, G. ; Magri, V. ; Naso, G. ; Presti, D. ; Mura, S. ; Fontana, A. ; Cognetti, F. ; Molinelli, C. ; Pastorino, S. ; Bighin, C. ; Lambertini, M. ; Del Mastro, L.

Annals of oncology, 2018-10, Vol.29, p.viii105-viii105 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients
Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients

Coltelli, L ; Cappelli, S ; Fontana, A ; Lucchesi, S ; Bocci, G ; Farnesi, A ; Arrighi, G ; Finale, C ; Salvadori, B ; De Angelis, C ; Ginocchi, L ; Falcone, A ; Fabiani, I ; Allegrini, G

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi41 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
8
Safety and efficacy of non-pegylated liposomal doxorubicin (NPLD) in HER2 negative metastatic breast cancer (mBC) patients (PTS) as second-line (2L) and beyond: a restrospective single institution analysis
Safety and efficacy of non-pegylated liposomal doxorubicin (NPLD) in HER2 negative metastatic breast cancer (mBC) patients (PTS) as second-line (2L) and beyond: a restrospective single institution analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and efficacy of non-pegylated liposomal doxorubicin (NPLD) in HER2 negative metastatic breast cancer (mBC) patients (PTS) as second-line (2L) and beyond: a restrospective single institution analysis

De Angelis, C ; Diodati, L ; Bertolini, I ; Montagnani, I ; Fontana, A ; Ferrarini, I ; Salvadori, B ; Ferrari, P ; Michelotti, A ; Landucci, E ; Falcone, A

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi42 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
9
The prognostic impact of sidedness across all stages during the last 20 years: the “Modena Cancer Registry” experience
The prognostic impact of sidedness across all stages during the last 20 years: the “Modena Cancer Registry” experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

The prognostic impact of sidedness across all stages during the last 20 years: the “Modena Cancer Registry” experience

Spallanzani, A. ; Gelsomino, F. ; Caputo, F. ; Salati, M. ; Reggiani Bonetti, L. ; Domati, F. ; Andrikou, K. ; Fontana, A. ; Di Emidio, K. ; Baldessari, C. ; Pugliese, G. ; Bettelli, S. ; Luppi, G. ; Cascinu, S.

Annals of oncology, 2017-10, Vol.28, p.vi10-vi10 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Outcome and prognostic factors after resection of liver metastases in patients with colorectal cancer
Outcome and prognostic factors after resection of liver metastases in patients with colorectal cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcome and prognostic factors after resection of liver metastases in patients with colorectal cancer

Baldessari, C ; Spallanzani, A ; Gelsomino, F ; Bettelli, S ; Pugliese, G ; Salati, M ; Caputo, F ; Andrikou, K ; Fontana, A ; Di Emidio, K ; Napolitano, M ; Kaleci, S ; Luppi, G ; Cascinu, S

Annals of oncology, 2017-10, Vol.28 Suppl 6, p.vi13-vi14 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.